Publications by authors named "Grace Dy"

Claim this Profile
E
Exosomal Thomsen-Friedenreich Glycoantigen as a Sensitive and Specific Biomarker for Colon, Ovarian and Prostate Cancer Diagnosis.
Yafei Su, Man Qi, Shoaib Vasini, Mary E Reid, Kate Rittenhouse-Olson, Grace K Dy

Cancers (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary Suffusion Refinements for Primary and Secondary Malignancies: Preliminary Analyses of Phase I Safety and Drug Delivery Data.
Todd Demmy, Samah Abdelhady, Garin Tomaszewski, Michael Petroziello, Omar Hasan, Grace Dy

Cancers (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular determinants of sotorasib clinical efficacy in KRAS-mutated non-small-cell lung cancer.
Ferdinandos Skoulidis, Bob T Li, Adrianus Johannes de Langen, David S Hong, Herve Lena, Grace K Dy, Anita Reddy

Nat Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CLO25-097: Randomized Phase II Study of Pembrolizumab 200mg q12 Weeks Versus Standard-of-Care (SOC) Dosing in Stage IV Non-Small Cell Lung Cancer (NSCLC) With Prior Clinical Benefit to Pembrolizumab Monotherapy.
Anuja V Abhyankar, Myung-Ju Ahn, Grace K Dy

J Natl Compr Canc Netw· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of the CDK4/6 inhibitor ribociclib combined with gemcitabine in patients with advanced solid tumors.
Aurora Norman, Mahesh Seetharam, Jacob Allred, Jianping Kong, Mateusz Opyrchal, Grace K Dy

BJC Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Divergent transcriptional states and kinetics of circulating tumor-infiltrating lymphocyte repertoires with highly homologous T-cell receptor sequences in a patient during immunotherapy.
Ryutaro Kajihara, Mark D Long, Toshifumi Hoki, Hongbin Chen, Takayoshi Yamauchi, Grace K Dy

J Immunother Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular adverse events associated with antibody-drug conjugates for cancer: evidence and management strategies.
Grace K Dy, Asim V Farooq, Joann J Kang

Oncologist· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of a recombinant attenuated oncolytic virus, MEDI5395 (NDV-GM-CSF), administered systemically in combination with durvalumab in patients with advanced solid tumors.
Diwakar Davar, Benedito A Carneiro, Grace K Dy, Siddharth Sheth, Mitesh J Borad

J Immunother Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Inhibitor Therapy and Associations with Clonal Hematopoiesis.
Abhay Singh, Nuria Mencia Trinchant, Rahul Mishra, Kirti Arora, Smit Mehta, Grace K Dy

Int J Mol Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients' Preferences for Adjuvant Osimertinib in Non-Small-Cell Lung Cancer After Complete Surgical Resection: What Makes It Worth It to Patients?
Muhammad Awidi, Angel Mier-Hicks, Stuthi Perimbeti, Kristopher Attwood, Hongbin Chen, Grace K Dy

Clin Lung Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sotorasib (960 mg or 240 mg) once daily in patients with previously treated KRAS G12C-mutated advanced NSCLC.
Maximilian J Hochmair, Karim Vermaelen, Giannis Mountzios, Enric Carcereny, Christophe Dooms, Grace K Dy, Wendy Snyder

Eur J Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tenascin-C in the early lung cancer tumor microenvironment promotes progression through integrin αvβ1 and FAK.
Shiela C Samson, Anthony Rojas, Rebecca G Zitnay, Keith R Carney, Wakeiyo Hettinga, Grace K Dy

bioRxiv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exosomal Thomsen-Friedenreich Glycoantigen: A New Liquid Biopsy Biomarker for Lung and Breast Cancer Diagnoses.
Chang-Chieh Hsu, Yafei Su, Kate Rittenhouse-Olson, Kristopher M Attwood, Wilfrido Mojica, Grace K Dy

Cancer Res Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trilaciclib use in extensive-stage small cell lung cancer (ES-SCLC): are clinical benefits seen in the real-world setting?
Joseph Elijah, Prantesh Jain, Allison Holdsworth, Jeffrey Baron, Eugene Przespolewski, Grace K Dy

Support Care Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Study of sequences of the CDK4/6 Inhibitor, Ribociclib Combined with Gemcitabine in Patients with Advanced Solid Tumors.
Mahesh Seetharam, Aurora Norman, Jacob Allred, Jianping Kong, Mateusz Opyrchal, Grace K Dy

Res Sq· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged Disease Control Despite ALK Inhibitor Discontinuation in Advanced ALK-Positive NSCLC.
Syed Ather Hussain, Hafsa Faisal, Grace K Dy

Eur J Case Rep Intern Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Characteristics and Treatment Responsiveness in Pembrolizumab-Treated Non-Small Cell Lung Carcinoma.
Haiyan Li, Sunitha Shyam Sunder, Karan Jatwani, Yongho Bae, Lei Deng, Grace K Dy

Cancers (Basel)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term benefit of sotorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: plain language summary.
Grace K Dy, Ramaswamy Govindan, Vamsidhar Velcheti, Gerald S Falchook, Antoine Italiano, Wendy Snyder

Future Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CodeBreak 200: study limitations, and future directions.
Malak Alharbi, Muhammad Awidi, Grace K Dy

Transl Cancer Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring undergraduates' understanding of the culture of scientific research as an outcome variable in research on CUREs.
Lexi Wachtell, Amanda Gardiner, Matt Sievers, Katie Dickinson, Grace E C Dy

J Microbiol Biol Educ· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in Humans.
Alexandra V Vylegzhanina, Ivan A Bespalov, Ksenia A Novototskaya-Vlasova, Brandon M Hall, Anatoli S Gleiberman, Grace K Dy

Cancer Res Commun· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Further Progression or Death Among Durable Progression-Free Survivors With Melanoma or Non-Small-Cell Lung Cancer in PD-1 Blockade Trials: Implications for Imaging Surveillance.
Lei Deng, Changchuan Jiang, Kristopher Attwood, Joseph J Zhao, Stuthi Perimbeti, Grace K Dy

JCO Oncol Pract· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-Specific Effects of Body Composition on Tumor Microenvironment in Non-Small Cell Lung Cancer: Obesity, Gender, and TME in NSCLC.
Yeshwanth Vedire, Robert Seager, Erik Van Roey, Shuang Gao, Mary Nesline, Grace Dy

Ann Thorac Surg Short Rep· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 Expression by RNA-Sequencing in Non-Small Cell Lung Cancer: Concordance with Immunohistochemistry and Associations with Pembrolizumab Treatment Outcomes.
Mary K Nesline, Rebecca A Previs, Grace K Dy, Lei Deng, Yong Hee Lee

Cancers (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluctuations in Gut Microbiome Composition During Immune Checkpoint Inhibitor Therapy.
Joy Sarkar, Eduardo Cortes Gomez, Takaaki Oba, Hongbin Chen, Grace K Dy

World J Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis